Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-801
Closed -$60.5K 5233
2026
Q1
$60.5K Sell
801
-1,116
-58% -$83.9K ﹤0.01% 1602
2025
Q4
$143K Buy
1,917
+483
+34% +$35.3K ﹤0.01% 1173
2025
Q3
$96.8K Buy
1,434
+1,085
+311% +$72K ﹤0.01% 1555
2025
Q2
$30K Sell
349
-36
-9% -$2.16K ﹤0.01% 1476
2025
Q1
$23.8K Buy
385
+101
+36% +$6.69K ﹤0.01% 1231
2024
Q4
$20.5K Sell
284
-2
-0.7% -$156 ﹤0.01% 1203
2024
Q3
$23.3K Buy
286
+8
+3% +$640 ﹤0.01% 1025
2024
Q2
$20.6K Buy
278
+270
+3,375% +$20.2K ﹤0.01% 951
2024
Q1
$624 Hold
8
﹤0.01% 1214
2023
Q4
$572 Buy
+8
New +$557 ﹤0.01% 1214
2023
Q3
Sell
-6
Closed -$486 1336
2023
Q2
$486 Buy
+6
New +$490 ﹤0.01% 1211
2020
Q4
$6K Buy
+86
New +$6.07K ﹤0.01% 608

Other funds holding HOLX

Arax Advisory Partners's HOLX Position: Q2 2026 in Review

Arax Advisory Partners sold out of Hologic (HOLX) in Q2 2026, closing a stake of 801 shares — an estimated $60.5K sold.

Arax Advisory Partners first reported a position in HOLX in Q4 2020 and held it in 12 quarters. The position peaked at $143K in Q4 2025. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Arax Advisory Partners reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Arax Advisory Partners sold 801 Hologic shares in Q2 2026, an estimated $60.5K.
  • Arax Advisory Partners first reported a position in Hologic in Q4 2020 and held it in 12 quarters.
  • Arax Advisory Partners's Hologic position peaked at $143K in Q4 2025.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.